Assessment of plasma and red cell trace element concentrations, disease severity, and outcome in patients with critical illness

Journal of Critical Care

Volumn 29, Issue 2, 2014, Pages 214-218

  Stefanowicz, Fiona ^a   Gashut, Rawia A ^b   Talwar, Dinesh ^a   Duncan, Andrew ^a   Beulshausen, Julia F ^b   McMillan, Donald C ^b   Kinsella, John ^b  

^a NHS Greater Glasgow and Clyde Clinical Biochemistry Service   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Copper; Critical illness; Selenium; Systemic inflammatory response; Zinc

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; COPPER; GLUTATHIONE PEROXIDASE; SELENIUM; TRACE ELEMENT; ZINC; ALBUMINOID;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD LEVEL; COPPER BLOOD LEVEL; CRITICAL ILLNESS; DISEASE SEVERITY; ENZYME BLOOD LEVEL; ERYTHROCYTE LEVEL; FEMALE; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUTRITIONAL STATUS; PROGNOSIS; SELENIUM BLOOD LEVEL; SURVIVOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VERY ELDERLY; ZINC BLOOD LEVEL; BLOOD; CHEMISTRY; ERYTHROCYTE; INTENSIVE CARE UNIT; MIDDLE AGED; ORGAN DYSFUNCTION SCORE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINS; C-REACTIVE PROTEIN; COPPER; CRITICAL ILLNESS; ERYTHROCYTES; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; NUTRITIONAL STATUS; ORGAN DYSFUNCTION SCORES; SELENIUM; SEVERITY OF ILLNESS INDEX; TRACE ELEMENTS; YOUNG ADULT; ZINC;

EID: 84896713780     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2013.10.012     Document Type: Article

References (43)

1. Thomas J.P., Maiorino M., Ursini F., et al. Protective action of phospholipid hydroperoxide glutathione-peroxidase against membrane-damaging lipid peroxidation-in-situ reduction of phospholipid and cholesterol hydroperoxides. J Biol Chem 1990, 265:454-461.
2. Fraker P.J., King L.E., Laakko T., et al. The dynamic link between the integrity of the immune system and zinc status. J Nutr 2000, 130:1399S-1406S.
3. Heyland D.K., Dhaliwal R., Suchner U., et al. Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Int Care Med 2005, 31:327-337.
4. Berger M.M., Spertini F., Shenkin A., et al. Trace element supplementation modulates pulmonary infection rates after major burns: a double-blind, placebo-controlled trial. Am J Clin Nutr 1998, 68:365-371.
5. Heyland D.K., Dhaliwal R., Day A.G., et al. REducing Deaths due to OXidative Stress (The REDOXS (c) Study): rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients. Proc Nutr Soc 2006, 65:250-263.
6. Berger M.M., Chiolero R.L. Antioxidant supplementation in sepsis and systemic inflammatory response syndrome. Crit Care Med 2007, 35:S584-S590.
7. Goode H.F., Cowley H.C., Walker B.E., et al. Decreased antioxidant status and increased lipid-peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 1995, 23:646-651.
8. Metnitz P.G.H., Bartens C., Fischer M., et al. Antioxidant status in patients with acute respiratory distress syndrome. Int Care Med 1999, 25:180-185.
9. Rinaldi S., Landucci F., De Gaudio A. Antioxidant therapy in critically septic patients. Curr Drug Targ 2009, 10:872-880.
10. Cander B., Dundar Z.D., Gul M., et al. Prognostic value of serum zinc levels in critically ill patients. J Crit Care 2011, 26:42-46.
11. Besecker B.Y., Exline M.C., Hollyfield J., et al. A comparison of zinc metabolism, inflammation, and disease severity in critically ill infected and non-infected adults early after intensive care unit admission. Am J Clin Nutr 2011, 93:1356-1364.
12. Manzanares W., Biestro A., Galusso F., et al. Serum selenium and glutathione peroxidase-3 activity: biomarkers of systemic inflammation in the critically ill?. Int Care Med 2009, 35:882-889.
13. Forceville X., Vitoux D., Gauzit R., et al. Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients. Crit Care Med 1998, 26:1536-1544.
14. Duncan A., Dean P., Simm M., et al. Zinc supplementation in intensive care: results of a UK survey. J Crit Care 2012, 27(102):e1-e6.
15. Galloway P., McMillan D.C., Sattar N. Effect of the inflammatory response on trace element and vitamin status. Ann Clin Bioch 2000, 37:289-297.
16. Duncan A., Talwar D., McMillan D.C., et al. Quantitative data on the magnitude of the systemic inflammatory response and its effect on micronutrient status based on plasma measurements. Am J Clin Nutr 2012, 95:64-71.
17. Oakes E.J.C., Lyon T.D.B., Duncan A., et al. Acute inflammatory response does not affect erythrocyte concentrations of copper, zinc and selenium. Clin Nutr 2008, 28:115-120.
18. Defi I.R., Yamazaki C., Kameo S., et al. Acute phase response of selenium status and glutathione peroxidase activity in blood plasma before and after total knee arthroplasty surgery. Biol Trace Element Res 2011, 144:388-395.
19. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992, 101:1644-1655.
20. Expert Group on Vitamins and Minerals Safe upper levels for vitamins and minerals http://cot.food.gov.uk/cotreports/cotjointreps/evmreport/.
21. Drabkin D.L., Austin J.H. Preparations from washed blood cells; nitric oxide haemoglobin determination by a simple effective method. J Biol Chem 1935, 112:51.
22. Fleck A., Raines G., Hawker F., et al. Increased vascular permeability, a major cause of hypoalbuminaemia in disease and injury. Lancet 1985, 1:781-784.
23. Burke R.F., Hill K.E., Motley A.K. Plasma selenium in specific and non-specific forms. Biofactors 2001, 14:107-114.
24. Nicholson J.P., Wolmarans M.R., Park G.R. The role of albumin in critical illness. Br J Anaes 2000, 85:599-610.
25. Deagen J.T., Butler J.A., Zachara B.A., et al. Determination of the distribution of selenium between glutathione peroxidase, selenoprotein P and albumin in plasma. Anal Biochem 1993, 208:176-181.
26. Harrison I., Littlejohn D., Fell G.S. Distribution of selenium in human blood plasma and serum. Analyst 1996, 121:189-194.
27. Mostert V., Lombeck I., Abel J. A novel method for the purification of selenoprotein P for human plasma. Arch Biochem Biophys 1998, 357:326-330.
28. Dreher I., Jakobs T.C., Köhrle J. Cloning and characterisation of the human selenoprotein P promoter. response of selenoprotein P expression to cytokines in liver cells. J Biol Chem 1997, 272:29364-29371.
29. Di Silvestro R.A. Effects of inflammation on copper antioxidant enzyme levels. Adv Exp Med Biol 1989, 258:253-258.
30. Nichol C., Herdman J., Sattar N. Changes in the concentrations of plasma selenium and selenoproteins after minor elective surgery: further evidence for a negative acute phase response. Clin Chem 1998, 44:1764-1766.
31. Daniels L., Gibson R., Simmer K. Randomised clinical trial of parenteral selenium supplementation in preterm infants. Arch Dis Child Fetal Neonatal Ed 1996, 74:F158-F164.
32. Nève J., Vertongen F., Capel P. Selenium supplementation in healthy Belgian adults in platelet glutathione peroxidase activity and other blood indices. Am J Clin Nutr 1988, 48:139-143.
33. Jacobson S., Plantin L.O. Concentration of selenium in plasma and erythrocytes during total parenteral nutrition in Crohn's disease. Gut 1985, 26:50-54.
34. Rea H.M., Thomson C.D., Campbell D.R., et al. Relation between erythrocyte selenium concentrations and glutathione peroxidase activities of New Zealand residents and visitors to New Zealand. Br J Nutr 1979, 42:201-212.
35. Stefanowicz F.A., Talwar D., O'Reilly D.S.J., et al. Erythrocyte selenium concentration as a marker of selenium status. Clin Nutr 2013, 95:64-71.
36. Buerk C.A. Zinc deficiency, effect on healing and metabolism in man. Surg Forum 1973, 14:101-103.
37. Prasad A.S. Experimental zinc deficiency in humans. Ann Int Med 1978, 89:483-490.
38. Baer M.T., King J. Tissue zinc levels and zinc excretion during experimental zinc depletion in young men. Am J Clin Nutr 1984, 39:556-570.
39. Okahata S., Nishi Y., Hatano S., et al. Changes in erythrocyte superoxide dismutase in a patient with copper deficiency. Eur J Pediatr 1980, 134:121-124.
40. Berger M.M., Reymond M.J., Shenkin A., et al. Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial. Int Care Med 2001, 27:91-100.
41. Berger M.M., Shenkin A., Revelly J.P., et al. Copper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in critically ill patients. Am J ClinNutr 2004, 80:410-416.
42. Avenell A., Noble D.W., Barr J., et al. Selenium supplementation for critically ill adults. Cochrane Database of Systematic Reviews 2004, (Issue 4).
43. Andrews P.J.D., Avenell A., Noble D.W. Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ 2011, 342:d1542.